The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OP-NEU-101: A phase 1/2 open-label, dose finding and expansion study to investigate the safety and effectiveness and determine the optimal dose of N17350 administered intratumorally in participants with advanced solid tumors.
 
Matteo Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; IDEAYA Biosciences; Innovent Biologics; Medison; Medison; Merck Serono; Moderna Therapeutics; MSD; Nektar; Novartis; OncoSec; Pierre Fabre; QBiotics; Regeneron; Roche; Sanofi; Strand Therapeutics
 
Emily Roberts-Thomson
Employment - Onchilles Pharma; Treadwell Therapeutics
Travel, Accommodations, Expenses - Onchilles Pharma; Treadwell Therapeutics
 
Glenn Michelson
Employment - CG Pharmaceuticals; novelty nobility; Onchilles Pharma; Treadwell Therapeutics
 
Alain Algazi
Stock and Other Ownership Interests - Onchilles Pharma; Sensei Biotherapeutics; Valitor
Consulting or Advisory Role - Onchilles Pharma; Sensei Biotherapeutics; Worldwide Clinical Trials
Research Funding - Acerta Pharma (Inst); Amgen (Inst); Ascendis Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); Genentech (Inst); Idera (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OncoSec (Inst); Oncosec (Inst); Sensei Biotherapeutics (Inst); Tessa Therapeutics (Inst); Vaccinex (Inst)
Travel, Accommodations, Expenses - OncoSec
 
Igor Puzanov
Stock and Other Ownership Interests - Compugen; IDEAYA Biosciences; IDEAYA Biosciences (I)
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; GI Innovation; IO Biotech; Ipsen; Mural Oncology
Research Funding - NIH/NCI (Inst)
(OPTIONAL) Uncompensated Relationships - Onchilles Pharma; Oncohost; Seneca Therapeutics
 
Kevin Harrington
Honoraria - Abbvie (Inst); ALX Oncology (Inst); AstraZeneca (Inst); BeiGene (Inst); Bicara Therapeutics (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Flamingo Pharma (Inst); GlaxoSmithKline (Inst); Johnson and Johnson (Inst); Merck Serono (Inst); Merus (Inst); MSD (Inst); Nanobiotix (Inst); PDS Biotechnology (Inst); PsiVac Ltd (Inst); QBiotics (Inst); Replimune (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Onchilles Pharma (Inst); Replimune (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Tanguy Seiwert
Honoraria - Merck
Consulting or Advisory Role - Arcus Biosciences; AstraZeneca; Bayer; BioNTech; BostonGene; Cue Biopharma; Eisai; Exelixis; Innate Pharma; IO Biotech; iTEOS Therapeutics; Merck; Nanobiotix; Onchilles Pharma; Regeneron; Sanofi; Seattle Genetics/Astellas; Surface Oncology; VIR Biotechnology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Nanobiotix (Inst)
Travel, Accommodations, Expenses - BostonGene; Coherus BioSciences; Nanobiotix
 
Peter Haberz
Employment - Onch
Stock and Other Ownership Interests - Onchilles Pharma
Patents, Royalties, Other Intellectual Property - Pending patent application assigned to Onchilles Pharma
Travel, Accommodations, Expenses - Onchilles Pharma
 
Ravindra Gujar
No Relationships to Disclose
 
Chang Cui
Employment - Onchilles Pharma
Stock and Other Ownership Interests - Onchilles Pharma
Research Funding - Onchilles Pharma
Patents, Royalties, Other Intellectual Property - Patents that are assigned to Onchilles Pharma
Travel, Accommodations, Expenses - Onchilles Pharma
 
Lev Becker
Employment - Onchilles Pharma
Stock and Other Ownership Interests - Macrologic; Maponos Therapeutics; Onchilles Pharma
Consulting or Advisory Role - Onchilles Pharma
Research Funding - Macrologic; Vertex
Patents, Royalties, Other Intellectual Property - Macrologic; Maponos Therapeutics; Onchilles Pharma
Travel, Accommodations, Expenses - Onchilles Pharma
Other Relationship - Macrologic; Maponos Therapeutics; Onchilles Pharma
(OPTIONAL) Uncompensated Relationships - Macrologic; Maponos Therapeutics; Onchilles Pharma